CATALAYER NEWS
Novartis takes $1.9bn writedown on key drug after blockbuster Avidity acquisition - Financial Times
Source: Financial Times · 2026-10-27
Full article text is available in the Catalayer news terminal.
MORE FROM FINANCIAL TIMES
ADT Secures AI Innovation with Oracle – Company Announcement - Financial Times
2026-10-27
Boeing shares slump as planemaker falls behind schedule in 737 jet production - Financial Times
2026-10-27
Wells Fargo & Company Announces Common Stock Dividend - Financial Times
2026-10-27
US insurance regulators back down on credit ratings scrutiny - Financial Times
2026-10-27
How good is the iPhone Duo? - Financial Times
2026-10-27
RELATED ON CATALAYER
Related Topics
Mergers & Acquisitions NewsRELATED MARKETS
Prediction Markets